Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Efficacy of antiplatelets in deep venous thrombosis
Venous thromboembolism (VTE) is the third most common cardiovascular disease in the world. Every year, 30,000 people in Australia develop VTE, at a cost of $1.72 billion to the Australian health system.
2018 PSA Offshore Refresher Conference
Delegates from the 43rd annual PSA Offshore Refresher conference have recently returned from host city San Francisco, where they networked while learning about the...
Pondering aged care
After starting my pharmacy career working in a neonatal intensive care unit, tending to the pharmacy needs of premature babies, I have now come...
Broadening pharmacists’ role to improve health
In 2023 pharmacists will be the custodians of medicine safety, embedded wherever medicines are used, and more responsible and accountable for the safe and...
Pharmacists play a key role in cow’s milk allergy diagnosis
ADVERTORIAL BY NUTRICIA
For many parents, the journey towards diagnosis of cow’s milk allergy in their baby is a long and difficult one. It is...
The impact of air pollution
Air pollution is making us sick according to local and global research, including a study linking exposure to air pollution with subsequent acute cardiac...
